← FDA Drug Approvals (Drugs@FDA)

DOCETAXEL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2021-01-14

Drug application

FDA Application #
ANDA204490
Application type
Abbreviated New Drug Application (Generic)
Brand name
DOCETAXEL
Generic name
DOCETAXEL
Active ingredients
DOCETAXEL
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
HIKMA
Manufacturer
Hikma Pharmaceuticals USA Inc.
First approval
2021-01-14

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown